ReviewThe Journal of rheumatology2019

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.

Ana-Maria Orbai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.